Remove 2026 Remove Doctors Remove Side effects
article thumbnail

Jazz Pharma uses flying pig for huge grey area DTC

World of DTC Marketing

billion by 2026. Jazz’s DTC for Sunosi says “if you have obstructive sleep apnea or narcolepsy and are often tired during the day, ask your doctor if once-daily SUNOSI may be right for you” but what they don’t mention is that obstructive sleep apnea is associated with obesity in more than 60% of cases.

Pharma 181
article thumbnail

FDA makes moves to advance ALS research ahead of upcoming Amylyx AdCom

Pharmaceutical Technology

The Act authorizes the appropriation of $100,000,000 per fiscal year from 2022 to 2026. Sanofi's Rilutek, which has generic versions available, has shown a 35% survival benefit in stage 4 ALS, but the drug has several side effects which affect the patient’s quality of life. The FDA’s action plan.

FDA 98